Jared Davis
9Patents
2h-index
20Co-inventors
43Inventor score
Filing activity: May 31, 2018 → Jul 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11015204B2 | Synthesis and structure of high potency RNA therapeutics | Chemistry; Metallurgy | 3 | Active |
| US10738286B2 | T7 RNA polymerase variants | Chemistry; Metallurgy | 2 | Active |
| US11744887B2 | Coronavirus vaccine compositions and methods | Emerging Cross-Sectional Technologies | 2 | Active |
| US11236311B2 | T7 RNA polymerase variants | Chemistry; Metallurgy | 1 | Active |
| US11759515B2 | Compositions and methods for inducing immune responses | Emerging Cross-Sectional Technologies | 1 | Active |
| US11236312B2 | T7 RNA polymerase variants | Chemistry; Metallurgy | 1 | Active |
| US12220455B2 | Coronavirus vaccine compositions and methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US12129494B2 | T7 RNA polymerase variants | Chemistry; Metallurgy | 0 | Active |
| US12390524B2 | Compositions and methods for inducing immune responses | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.